Zou Liyun

Zou Liyun


Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2005 in Clinical Chemistry
Verified
Journal Article
Open access
PDF file
YLYunfei Liang
Yunfei Liang
YWYing Wan
Ying Wan
LQLi-Wen Qiu
Li-Wen Qiu
JZJingran Zhou
Jingran Zhou
BNBing Ni
Bing Ni
YWYuzhang Wu
Yuzhang Wu
Background: The epidemic outbreak of severe acute respiratory syndrome (SARS) posed a worldwide threat to public health and economic stability. Although the pandemic has been contained, concerns over its recurrence remain. It is essential to identify specific diagnostic agents and antiviral vaccine candidates to fight this highly contagious disease. Methods: We generated 14 monoclonal antibodies (mAbs) specific to the SARS coronavirus (SARS-CoV) nucleocapsid (N) protein and used these to thoroughly map the N protein antigenic determinants. We identified the immunodominant antigenic sites responsible for the antibodies in sera from SARS patients and antisera from small animals and differentiated the linear from the conformational antibody-combining sites comprising the natural epitopes by use of yeast surface display. Results: We identified 5 conformational and 3 linear epitopes within the entire N protein; 3 conformational and 3 linear epitopes were immunodominant. The antibody responses to the N protein fragments in mammalian sera revealed that 3 regions of the N protein are strong antigenic domains. We expanded the specificity of the N protein epitope and identified 4 novel conformational epitopes (amino acids 1–69, 68–213, 212–341, and 337–422). Conclusion: The antigenic structures identified for the SARS-CoV N protein, the epitope-specific mAbs, and the serum antibody profile in SARS patients have potential use in the clinical diagnosis and understanding of the protective immunity to SARS-CoV.

5 July 2025 in Genes & Immunity
Verified
Journal Article
Closed access
PDF file
YLYubo Liu
Yubo Liu
YZYiwen Zhou
Yiwen Zhou
JZJi Zhang
Ji Zhang
LJLi Jingyi
Li Jingyi
ZLZou Liyun
Zou Liyun

1 May 2005 in Journal of Virology
Verified
Journal Article
Open access
PDF file
ACAn Chen
An Chen
LWLi Wang
Li Wang
JZJingbo Zhang
Jingbo Zhang
ZLZou Liyun
Zou Liyun
ZJZhengcai Jia
Zhengcai Jia
YWYuzhang Wu
Yuzhang Wu
It is necessary to evaluate the cytokine secretion status of CD8+T lymphocytes and elucidate the factors influencing cytokine secretion, because the secretion of cytokines is also an important feature of CD8+T lymphocytes, and the cytokines usually play critical roles in the outcome of diseases. We showed here that peptide AYRPPNAPI, derived from the core antigen of hepatitis B virus (HBV), could bind to H-2 Kdand induce primed splenocytes from HBcAg expression plasmid-immunized mice to produce gamma interferon (IFN-γ) in H-2 Kd- and CD8-dependent manners instead of in a CD4-dependent manner. The induced cells were mainly CD3 and CD8 positive but had no cytotoxic effect on the corresponding target cells. When administered into HBV transgenic mice, these cells can decrease the serum HBV load without causing liver damage. These results suggest that this peptide is a special kind of CD8+T-cell epitope, for which specific CD8+T cells can produce IFN-γ when antigenic stimulation is encountered but which have no cytotoxic effect on the corresponding target cells both in vitro and in HBV transgenic mice. This phenomenon indicates initially that the functional mechanisms of CD8+T cells can be determined by their epitope specificity, which may be associated with the development of epitope-based immunotherapeutic approaches for infectious diseases and tumors.